Acuren Corporation (TIC) AI Stock Analysis

• Market Cap: $2.32B
• Dividend Yield: N/A
• Average Volume (3M): 3.19M
• Price to Earnings (P/E): ―
• Beta (1Y): 0.38
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: US
• Employees: 5,498
• Sector: Industrials
• Sector Strength: 72
• Industry: Specialty Business Services
• EPS (TTM): -0.08
• Shares Outstanding: 220,559,710
• 10 Day Avg. Volume: 2,585,001
• 30 Day Avg. Volume: 3,192,768
• PEG Ratio: 1.04
• Price to Book (P/B): 1.27
• Price to Sales (P/S): 2.30
• P/FCF Ratio: -137.36
• Enterprise Value/Market Cap: 1.63
• Enterprise Value/Revenue: 3.71
• Enterprise Value/Gross Profit: 14.01
• Enterprise Value/Ebitda: 28.45
• 1Y Price Target: $14.50
• Price Target Upside: 38.10% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 3
• EPS Forecast (FY): 0.06
• Revenue Forecast (FY): $1.54B

• Rating: 56 Neutral
• Price Target: $10.00 ▼(-4.76% Downside)

Acuren Corporation's overall stock score reflects significant financial challenges, particularly in revenue and profitability. While technical indicators suggest a bearish trend, the earnings call and corporate events provide some positive outlook with strategic growth and strengthened financial position. However, the lack of valuation metrics adds uncertainty to the stock's attractiveness.

Positive Factors

Consulting Engineering Segment Expansion

The double-digit growth in the Consulting Engineering segment indicates strong demand and potential for sustained revenue expansion, enhancing Acuren's market position and competitive edge.

Strong Balance Sheet and Liquidity

The $250 million private placement improves financial flexibility, supporting growth initiatives and enhancing Acuren's ability to invest in long-term strategic opportunities.

Increased Synergy Targets

Raising synergy targets to $25 million reflects successful integration efforts, which can lead to improved operational efficiency and profitability over the long term.

Negative Factors

Declining Revenue and Profitability

Declining revenues and profitability issues indicate potential challenges in maintaining market share and financial health, necessitating strategic adjustments.

Inspection and Mitigation Segment Decline

The decline in the Inspection and Mitigation segment suggests vulnerabilities in specific markets, potentially impacting overall revenue stability and growth.

Increased SG&A Expenses

Rising SG&A expenses can pressure margins and profitability, highlighting the need for cost control measures to sustain long-term financial performance.

Acuren Corporation Business Overview & Revenue Model

Company Description

TIC Solutions, Inc. engages in providing nondestructive testing, inspection, engineering and lab testing services. It operates through the United States and Canada segments. The company was founded in 1974 and is headquartered in Tomball, TX.

How the Company Makes Money

Acuren Corporation generates revenue primarily through the provision of its inspection and testing services. The company operates on a fee-for-service model, where clients pay for the specific services rendered, such as NDT, inspection, and engineering consultations. Key revenue streams include long-term service contracts with major industrial clients, project-based engagements, and ongoing maintenance and inspection agreements. Additionally, Acuren may benefit from partnerships with equipment manufacturers and industry associations that enhance its service offerings and market reach, thereby contributing to its overall earnings. The company's strong reputation and expertise allow it to secure repeat business and referrals, further bolstering its financial performance.

Acuren Corporation Financial Statement Overview

Summary

Acuren Corporation is facing financial challenges with declining revenues and profitability issues. The balance sheet shows a strong equity base, but liquidity challenges are evident, necessitating strategic initiatives for revenue growth and cost management.

Income Statement

Acuren Corporation has seen a significant drop in revenue from the previous year, translating to a negative revenue growth rate. The gross profit margin stands at 25.55%, indicating moderate efficiency in controlling production costs. However, the company is facing challenges with profitability, as evidenced by a negative net profit margin of -2.48% and a significant decline in EBIT and EBITDA margins to 5.59%. This highlights the need for improved cost management and revenue generation strategies.

Balance Sheet

The balance sheet reveals a strong equity position with an equity ratio of 52.15%, indicating stability and a solid asset base. However, the debt-to-equity ratio is 0.71, suggesting moderate leverage which could pose a risk if not managed carefully. The return on equity is negative at -1.36%, reflecting the current struggles with profitability.

Cash Flow

The cash flow statement shows declining free cash flow, with a negative free cash flow growth rate, indicating liquidity challenges. The operating cash flow to net income ratio is 0.17, suggesting inefficiencies in converting revenue into cash. The free cash flow to net income ratio is negative due to negative free cash flow, necessitating a focus on cash management and operational efficiencies.

Breakdown	TTM	Dec 2024	Dec 2023
Income Statement
Total Revenue	1.02B	1.10B	1.05B
Gross Profit	270.50M	265.66M	239.52M
EBITDA	133.22M	87.08M	150.56M
Net Income	-39.92M	-121.16M	-6.29M
Balance Sheet
Total Assets	4.22B	2.21B	1.26B
Cash, Cash Equivalents and Short-Term Investments	164.43M	139.13M	87.06M
Total Debt	1.72B	812.58M	730.00M
Total Liabilities	2.27B	1.06B	880.62M
Stockholders Equity	1.95B	1.15B	382.00M
Cash Flow
Free Cash Flow	530.90K	-4.51M	73.67M
Operating Cash Flow	28.72M	23.07M	95.81M
Investing Cash Flow	-1.15B	-1.89B	-26.53M
Financing Cash Flow	1.16B	1.42B	-49.18M

Acuren Corporation Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 10.50
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TIC, the sentiment is Neutral. The current price of 10.5 is above the 20-day moving average (MA) of 9.98, below the 50-day MA of 10.77, and below the 200-day MA of 11.03, indicating a neutral trend. The MACD of -0.02 indicates Negative momentum. The RSI at 54.06 is Neutral, neither overbought nor oversold. The STOCH value of 43.72 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TIC.

Acuren Corporation Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CDRE	80 Outperform	$1.74B	38.18	14.17%	0.90%	19.94%	33.38%
LNN	73 Outperform	$1.27B	17.34	14.61%	1.24%	11.41%	13.05%
Sector *	63 Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
TNC	59 Neutral	$1.36B	25.78	8.51%	1.59%	-2.24%	-48.77%
DCO	58 Neutral	$1.47B	-41.89	-5.27%	―	3.16%	-213.56%
TIC	56 Neutral	$2.32B	―	―	―	―	―
EH	43 Neutral	$982.63M	-31.06	-24.60%	―	23.58%	20.74%

Acuren Corporation Corporate Events

Acuren Corporation Completes $250 Million Private Placement

TIC Solutions reported strong third-quarter 2025 financial results, with revenue of $473.9 million and an adjusted EBITDA of $77.3 million, reflecting the benefits of its merger with NV5 Global, Inc. The merger, completed on August 4, 2025, has created a market-leading $2 billion-plus TICC and engineering services business, enhancing the company’s diversification and synergy targets. Despite a net loss of $13.9 million, the company has improved its financial performance compared to previous periods, driven by increased demand across end markets and successful integration efforts. The company also completed a $250 million private placement in October 2025 to strengthen its balance sheet and support integration initiatives.

Acuren Corporation Completes $250M Private Placement

On October 5, 2025, Acuren Corporation entered into a Securities Purchase Agreement for a private placement of approximately $250 million worth of its common stock and pre-funded warrants. The private placement, which closed on October 7, 2025, is intended to fund general corporate purposes. The agreement includes a Registration Rights Agreement, obligating Acuren to file a registration statement with the SEC to register the resale of the shares. This strategic move is expected to bolster Acuren’s financial position and operational capabilities, potentially impacting its market presence and stakeholder interests.